We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Antioxidant Nanoparticles Neutralize Superoxide and Restore Blood Flow Following Traumatic Brain Injury

By LabMedica International staff writers
Posted on 05 Sep 2012
A novel class of potent antioxidant nanoparticles restores brain blood flow and normalizes superoxide and nitric oxide levels in the brains of a rat model of traumatic brain injury (TBI).

Cerebrovascular dysfunction, manifested by reduction in cerebral blood flow (CBF), is a key factor that worsens outcome after TBI, most notably under conditions of hypotension. More...
In a traumatic brain injury, damaged cells release an excessive amount of the reactive oxygen species (ROS) superoxide (SO) into the blood. Healthy organisms balance SO with increased production of the neutralizing enzyme superoxide dismutase (SOD), but even mild brain trauma can release superoxides at levels that overwhelm the brain’s capacity for SOD synthesis.

Based on data accumulated in studies designed to enhance cancer treatment via nanoparticle-based drug delivery, investigators at Rice University (Houston, TX, USA) decided to test their potential for treating TBI. These poly(ethylene glycol)-functionalized hydrophilic carbon clusters (PEG-HCCs) represent a new class of nontoxic, antioxidant carbon-based nanoparticles.

PEG-HCCs were administered to a mild TBI/hypotension/resuscitation rat model during resuscitation, which is a clinically relevant time point. Results published in the August 6, 2012, online edition of the journal ACS Nano revealed that the particles rapidly restored CBF. Along with restoration of CBF, there was a concomitant normalization of superoxide and nitric oxide levels.

“Superoxide is the most deleterious of the reactive oxygen species, as it is the progenitor of many of the others,” said senior author Dr. James M. Tour, professor of chemistry, mechanical engineering, and materials science at Rice University. “If you do not deal with SO, it forms peroxynitrite and hydrogen peroxide. SO is the upstream precursor to many of the downstream problems. While an SOD enzyme can alter only one superoxide molecule at a time, a single PEG-HCC about the size of a large protein at two to three nanometers wide and 30 to 40 nanometers long can quench hundreds or thousands. This is an occasion where a nano-sized package is doing something that no small drug or protein could do, underscoring the efficacy of active nano-based drugs.”

“This might be a first line of defense against reactive oxygen species (ROS) that are always overstimulated during a medical trauma, whether that be to an accident victim or an injured soldier,” said Dr. Tour. “They are certainly exacerbated when there is trauma with massive blood loss.”

Related Links:
Rice University




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Portable POCT Blood Gas Analyzer
BD100
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Graphical Abstract (Turner N, Keam S, Abdel-Wahab N, et al. B cell-guided inflammatory cascade perpetuates ICI-mediated colitis. Cell Reports (2026). doi:10.1016/j.celrep.2026.117969)

Blood-Based Biomarker May Predict Colitis Risk During Checkpoint Inhibitor Therapy

Immune checkpoint inhibitors can trigger immune-related colitis that leads to severe diarrhea, abdominal pain, and treatment interruptions. Clinicians currently lack validated tools to identify which patients... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.